Roman Avakovich Khanferyan

Roman Avakovich Khanferyan

Auto-generated profile, based on publicly available information

Roman Avakovich Khanferyan

Peoples' Friendship University of Russia

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Clinical Drug Investigation
Verified
Journal Article
Closed access
PDF file
MFMarta Ferrer
Marta Ferrer
MMMário Morais-Almeida
Mário Morais-Almeida
MGMargarita Guizova
Margarita Guizova
RKRoman Khanferyan
Roman Khanferyan

20 May 2023 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
VGV. B. Grinevich
V. B. Grinevich
LLL. B. Lazebnik
L. B. Lazebnik
YKYu. A. Kravchuk
Yu. A. Kravchuk
VRV. G. Radchenko
V. G. Radchenko
ETE. I. Tkachenko
E. I. Tkachenko
AKAnatoly Khavkin
Anatoly Khavkin
Summary Post- COVID syndrome refers to the long-term consequences of a new coronavirus infection COVID-19, which includes a set of symptoms that develop or persist after COVID-19. Symptoms of gastrointestinal disorders in post- COVID syndrome, due to chronic infl ammation, the consequences of organ damage, prolonged hospitalization, social isolation, and other causes, can be persistent and require a multidisciplinary approach. The presented clinical practice guidelines consider the main preventive and therapeutic and diagnostic approaches to the management of patients with gastroenterological manifestations of postCOVID syndrome. The Guidelines were approved by the 17th National Congress of Internal Medicine and the 25th Congress of Gastroenterological Scientifi c Society of Russia.

22 May 2020 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
TPT. L. Pilat
T. L. Pilat
ЛКЛ. П. Кузьмина
Л. П. Кузьмина
ELElena A. Lashina
Elena A. Lashina
MKM. M. Kolyaskina
M. M. Kolyaskina
LBL. M. Bezrukavnikova
L. M. Bezrukavnikova
RKR. A. Khanferyan
R. A. Khanferyan
Опыт применения специализированного пищевого продукта диетического лечебного и диетического профилактического питания при воспалительных заболеваниях желудочно-кишечного тракта


21 May 2023 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
ODOxana M. Drapkina
Oxana M. Drapkina
LLL. B. Lazebnik
L. B. Lazebnik
IBIgor G. Bakulin
Igor G. Bakulin
MZM. S. Zhuravleva
M. S. Zhuravleva
NBN. V. Bakulina
N. V. Bakulina
ЮКЮ. Г. Кузнецова
Ю. Г. Кузнецова
Clostridioides difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea, and an important cause of nosocomial infection. Since the publication of the National Guidelines (2016, 2017), new data have been accumulated on the genetic structure and pathogenic properties of the most common causative agent of severe forms of antibiotic- associated diarrhea, which has led to the reclassifi cation of the pathogen, formerly known as Clostridium diffi cile, to Clostridioides difficile. Laboratory algorithms have been developed to diagnose CDI and determine the toxigenicity of strains reliably. New data on the effectiveness of antibacterials have been published, monoclonal antibodies to toxin B (bezlotoxumab) have been introduced into clinical practice to prevent CDI recurrence, and fecal microbiota transplantation has been proposed. Over the past 5 years, many international guidelines on the management of adult patients with CDI have also been updated (USA, EU). In the last decade, including due to the COVID-19 pandemic, there has been an increase in CDI incidence. Considering therelevance of CDI, new data on the pathogen, and domestic features, the Russian Scientific Medical Society of Internal Medicine, the Gastroenterological Scientific Society of Russia, and the North-West Society of Gastroenterologists and Hepatologists developed these clinical guidelines.

20 April 2021 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
TPT. L. Pilat
T. L. Pilat
SAS. N. Alekseenko
S. N. Alekseenko
VKV. A. Krutova
V. A. Krutova
MAM. Yu. Akimov
M. Yu. Akimov
IRI. V. Radysh
I. V. Radysh
RKR. A. Khanferyan
R. A. Khanferyan
Introduction. One of the most significant issues that require close attention in the treatment and rehabilitation of patients with coronovirus infection is the analysis of the nutritional status of patients and the development of approaches to nutritional support for patients.Aim of study. Analysis of nutritional status of patients infected with COVID-19 and studying the effectiveness of specialized products dietary therapeutic and preventive nutrition during illness and recovery period.Materials and methods. A survey of 283 patients with mild and moderate severity was conducted. The survey showed a significant change in eating behavior in patients during the disease. To assess the effectiveness of nutritional support during the disease and during the recovery period, 36 individuals took a specialized product of dietary therapeutic and preventive nutrition “Detoxifying Kissel” LEOVIT DETOX daily after the diagnosis of COVID-19, both throughout the entire period of the disease, and within 2 weeks after the disease and going to work.Results and discussion. The survey showed the presence of a significant range of eating disorders in patients with coronavirus disease. It was found that in 90% of the respondents during the day, the main meal was 3 or more times. During the disease, the number of main meals decreased in 40% of individuals, and only in 4% of patients this figure increased. When using nutritional support with dietary therapeutic and prophylactic foods during the disease, patients noted a significant decrease in weakness and fatigue, temperature fluctuations, fears, anxiety, suspiciousness and other symptoms began to disappear. The continuation of the intake in the post-ovoid period of the use of nutritional support with the dietary therapeutic and preventive food product “Detoxifying Kissel” LEOVIT DETOX, contributes to a faster recovery of patients.Conclusion. The use of the dietary therapeutic and preventive food product “Detoxifying Kissel” LEOVIT DETOX is an effective method of nutritional support both during the disease and in the post-ovoid period. Long-term use of detoxification products (at least 3–6 months) after the disease is recommended.